Cell viability

QN Qi Nie
WC Wenqing Chen
TZ Tianmei Zhang
SY Shangrong Ye
ZR Zhongyu Ren
PZ Peng Zhang
JW Jian Wen
request Request a Protocol
ask Ask a question
Favorite

Following digestion with 0.25% EDTA-free trypsin (cat. no. C0205; Shanghai Biyuntian Biotechnology Co., Ltd.), the NCI-H446 and M059K cells were separately counted and adjusted to a cell suspension of 5×104 cells/ml. Subsequently, 100 µl cell suspension was transferred to each well of a 96-well cell culture plate and cultured for 24 h. After discarding the old culture medium, 100 µl NCI-H446 cells (or M059K cells) were treated with IONP (0.7 µg/ml), PTX (0.3 µg/ml), IONP (0.7 µg/ml) + PTX (0.3 µg/ml), and XTP@PNOI (1.0 µg/ml) at 37°C for 24 h. Simultaneously, untreated cells were set as a negative control. Thereafter, 10 µl Cell Counting Kit-8 solution (cat. no. KGA317; Nanjing KeyGen Biotech Co., Ltd.) was added to each well and incubated for another 2 h. After shaking gently for 10 min, the optical density (OD) of each well was detected at 450 nm on a microplate reader (BioTek ELx800; BioTek) and cell growth inhibitory rate was calculated using the formula: Inhibitory rate (%)=[(OD of control group-OD of experimental group)/(OD of control group-OD of blank group)] ×100. As shown in a previous study (57), the calculation formula of drug interaction was calculated using the following formula: combination index=Ea+b/(Ea + Eb-Ea × Eb), where a and b are any two treatments, Ea+b is the inhibitory rate of the combined a and b treatments, and Ea and Eb are separately the inhibitory rates of a and b. A combination index between 0.85 and 1.15 shows an additive effect and its value >1.15 shows synergistic interactions.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A